Prognostic and histologic significances of the expression profile of membrane tissue factor for aggressive endometrial carcinomas
The Oncologist · 2026
DOI: 10.1093/oncolo/oyag053 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Oncologist, 2026. Verfasst von Kaoru Fujieda und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Thromboplastin, Biomarkers, Tumor. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Tissue factor (TF) is involved in tumor-induced coagulation cascade, which plays crucial roles in the tumor microenvironment, and is being clinically explored as a therapeutic target. However, the prognostic role of TF and the related proteins in endometrial cancer is yet to be clarified and was systematically investigated in this study. Materials and Methods The expression profiles of membrane/cytoplasmic TF, nuclear/cytoplasmic phospho-TF (p-TF), PAR-1, PAR-2, VEGF as well as CD8, a marker for cytotoxic T cells, in tumors from 229 patients with endometrial carcinoma were immunohistochemically evaluated and correlated with clinicopathologic parameters and patient survival. Bioinformatics analyses were further conducted to strengthen the observations.
Results
High membrane TF (mTF) expression correlated with worse overall survival (OS), and was found to be an independent prognostic factor for unfavorable OS by the univariate and multivariate analyses (P = .028 and .0087). High mTF expression correlated with aggressive histology, and remained independent for unfavorable OS even in the aggressive histological subset (P = .037 and .0064). Moreover, mTF expression inversely correlated with CD8+ tumor-infiltrating immune cell count, and TF expression positively correlated with the infiltration of Treg cells, known to suppress CD8+ T cells, by the The Cancer Genome Atlas (TCGA) data analysis (P = .037 and .0015), suggesting that the detrimental prognostic role of mTF involves immune evasion.
Conclusions
Taken together, mTF serves as a potential biomarker for patient prognosis and therapeutic target for the aggressive histological type of tumor, providing significant rationales for incorporating TF-directed drugs into the novel strategy for refractory endometrial carcinomas.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan.
- Doctoral Program in Obstetrics and Gynecology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki 305- 8575, Japan.
ORCID-Profile: Takeo Minaguchi
Zitieren
APA
Fujieda, K., Minaguchi, T., Ono, K., Kuboya, T., Suto, A., Qi, N., Itagaki, H., Tenjimbayashi, Y., Shikama, A., Akiyama, A., Nakao, S., Kobayashi, Y., & Satoh, T. (2026). Prognostic and histologic significances of the expression profile of membrane tissue factor for aggressive endometrial carcinomas. The Oncologist. https://doi.org/10.1093/oncolo/oyag053
Vancouver
Fujieda K, Minaguchi T, Ono K, Kuboya T, Suto A, Qi N, et al. Prognostic and histologic significances of the expression profile of membrane tissue factor for aggressive endometrial carcinomas. The Oncologist. 2026. doi:10.1093/oncolo/oyag053
BibTeX
@article{Fujieda2026,
author = {Fujieda, Kaoru and Minaguchi, Takeo and Ono, Kaori and Kuboya, Takuya and Suto, Asami and Qi, Nan and Itagaki, Hiroya and Tenjimbayashi, Yuri and Shikama, Ayumi and Akiyama, Azusa and Nakao, Sari and Kobayashi, Yusuke and Satoh, Toyomi},
title = {Prognostic and histologic significances of the expression profile of membrane tissue factor for aggressive endometrial carcinomas},
journal = {The Oncologist},
year = {2026},
doi = {10.1093/oncolo/oyag053}
}
EUVIMED